DoD Arthritis, Focused Research Award
ID: 356100Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356100
Timeline
    Description

    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Arthritis Focused Research Award (FRA) to support innovative research aimed at improving patient care and quality of life for individuals affected by various forms of arthritis, particularly in relation to military personnel. This grant opportunity encourages applications that explore high-risk, potentially high-reward research addressing all types of arthritis, with a focus on the impact of arthritis on military readiness and health. The program has an estimated total funding of $2.5 million, with awards expected to be made by September 30, 2025, and applications must be submitted by October 30, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT9425FY24ATRPFRA_GG.pdf
    The DOD FY24 Arthritis Focused Research Award, managed by the U.S. Army Medical Research Acquisition Activity, provides up to $10 million in funding for innovative research focused on various forms of arthritis, particularly that affecting Service Members' health and retention. Applications are encouraged from extramural and intramural organizations, with important deadlines set for pre-application and application submissions in October 2024. The program emphasizes research areas like prevention, diagnosis, and intervention/treatment of arthritis, and includes two distinct funding levels based on the stage of research proposed: Research Level 1 for exploratory studies and Research Level 2 for preclinical to clinical translation research. The goal is to significantly reduce arthritis' impact on military readiness and wellness. All applications will undergo rigorous peer and programmatic review processes, evaluating criteria like impact, research strategy, and feasibility. Successful proposals are expected to eventually benefit both military and civilian populations. Detailed application guidance, eligibility requirements, and submission protocols are outlined, emphasizing a structured approach to foster collaboration and innovation in arthritis research.
    Similar Opportunities
    DoD Arthritis Research, Clinical Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Arthritis Research Clinical Research Award (ATRP CRA) to support clinical research aimed at improving the understanding and management of various forms of arthritis, particularly in military personnel and their families. This grant program encourages innovative research proposals that address disease-specific factors and interventions, with a focus on enhancing patient outcomes and informing clinical care or policy. With an estimated total funding of $6 million, the program anticipates awarding approximately three grants, including one for a clinical trial, with applications due by October 30, 2024, and a pre-application deadline of October 16, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Orthopaedic, Applied Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army's USAMRAA is offering the FY24 Peer Reviewed Orthopaedic Applied Research Award, aimed at funding applied research to enhance care for military personnel suffering from combat-related orthopaedic injuries. The program seeks innovative solutions that can translate into clinical applications, focusing on areas such as limb stabilization and battlefield care strategies, while excluding pure basic research. With an estimated total funding of $3.75 million to support approximately five awards, each capped at $750,000 over a maximum three-year period, interested applicants must submit pre-applications by June 18, 2024, followed by full applications due by September 17, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Orthopaedic, Clinical Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Peer Reviewed Orthopaedic Clinical Translational Research Award (CTRA) to support innovative research aimed at addressing significant gaps in orthopaedic care, particularly for military personnel with combat-related injuries. This funding opportunity encourages proposals that focus on enhancing treatment options and rehabilitation strategies for orthopaedic injuries, with an emphasis on interdisciplinary collaboration and clinical relevance. The total estimated funding for this program is $6 million, with a maximum award amount of $1.5 million per project, and applications are due by September 17, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Orthopaedic, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 (FY24) Peer Reviewed Orthopaedic Clinical Trial Award aimed at enhancing recovery from combat-related orthopaedic injuries. This grant supports clinical trials that focus on innovative treatment strategies, including limb stabilization, battlefield care, and rehabilitation, with an emphasis on interdisciplinary collaboration to improve military readiness and patient care. With an estimated total program funding of $13.25 million, the program anticipates awarding up to four grants of $2.5 million each for standard projects and one grant of $3.25 million for collaborative care projects. Interested applicants must submit pre-applications by June 18, 2024, and full applications by September 17, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org.
    DoD Peer Reviewed Orthopaedic, Women's Health Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Orthopaedic Women's Health Research Award (WHRA) for fiscal year 2024, aimed at supporting innovative research on orthopaedic injuries specifically affecting women in military settings. This funding opportunity seeks to address the unique challenges faced by female service members, with a focus on enhancing recovery and improving quality of life post-injury, while also contributing to broader healthcare knowledge applicable to all individuals with orthopaedic injuries. The total estimated funding for this program is approximately $3 million, with individual awards capped at $1.5 million and a maximum research duration of three years. Interested applicants must submit a pre-application via the Electronic Biomedical Research Application Portal (eBRAP) by September 17, 2024, and can direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    DoD Multiple Sclerosis, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Multiple Sclerosis Research Program (MSRP) via the Investigator-Initiated Research Award (IIRA). This grant aims to support innovative and high-impact research projects related to Multiple Sclerosis (MS), particularly those that can enhance patient care and quality of life, while excluding clinical trials. The program emphasizes research on central nervous system repair, disease progression correlates, symptom biology, and MS etiology, with a total funding pool of $6 million expected to yield approximately six awards, each up to $1 million over three years. Interested applicants must submit a pre-application by June 10, 2024, followed by a full application due by October 7, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Multiple Sclerosis, Exploration - Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Multiple Sclerosis Exploration - Hypothesis Development Award (MSRP EHDA), aimed at fostering innovative research in the field of multiple sclerosis (MS). This grant program supports high-risk, high-gain research concepts that challenge existing paradigms and lay the groundwork for future scientific investigations, with a focus on areas such as central nervous system repair and mechanisms contributing to MS etiology. The total estimated funding for this program is approximately $2 million, with an expected eight awards, and applications must follow a two-step submission process, including a pre-application due by June 10, 2024, and a full application due by October 7, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    CDMRP Neurofibromatosis Investigator-Initiated Research Program
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Neurofibromatosis Investigator-Initiated Research Program (NFRP) grant to support innovative research projects focused on neurofibromatosis (NF). This program aims to enhance understanding, diagnosis, and treatment of NF1, NF2, and schwannomatosis, with a particular emphasis on improving the quality of life for affected individuals, including military personnel and veterans. The total estimated funding for this initiative is $5.36 million, with up to six awards anticipated, and applications must be submitted by October 3, 2024, following a pre-application deadline of September 12, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Tick-Borne Disease Therapeutic/Diagnostic Research Award to support innovative research aimed at addressing tick-borne diseases, particularly Lyme disease. This grant seeks applications focused on therapeutic and diagnostic development with demonstrated feasibility, emphasizing projects that can improve patient care and quality of life for military Service Members, Veterans, and the general public. With an estimated total program funding of $2,656,000 and the expectation of awarding two grants, applicants must submit a pre-application through eBRAP by October 3, 2024, followed by a full application via Grants.gov upon invitation. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.